
RadioSyn
RadioSyn is designing and manufacturing a miniaturized automated radiopharmaceutical synthesis platform. We deliver a shielded, state-of-the-art synthesizer that eliminates traditional production barriers and complexity. Our automated synthesis technology platform addresses critical limitations in conventional diagnostic and therapeutic workflows by standardizing and streamlining radioimmunoconjugate and radiopharmaceutical manufacturing.
Our Platform

Our platform uses disposable microfluidic chips that perform end-to-end chemical and radiochemical reactions. The Radiosyn platform offers reproducible, high-quality radiopharmaceutical production across research and clinical settings, requiring minimal specialized radiochemistry expertise. The device offers cost-effective, on-demand delivery of radiopharmaceuticals, making it ideal for meeting the growing demand for personalized and precision medicine. Our mission is to accelerate scientific discovery and clinical use of radiopharmaceuticals by making their production more accessible, standardized, and scalable.
Our Team
.jpeg)
Dr. Sam Sadeghi
CEO, Co-founder
.jpeg)
Ali Mohammadi
Microfluidic Engineer
.jpeg)
Stefano Biasi
Radiochemist
.jpeg)
Shereecia Bangura
Research Assistant

Dr. Ravi Selvaganapathy
CTO, Co-founder
.jpeg)
Shayan Jahangirifard
Senior Engineer, Co-founder
.jpeg)
Matthew McLennan
Research Assistant
.jpeg)
Patricia Mallari
Quality Assurance
.jpeg)
Caden Roberts
Research Assistant
Our Partners

